Melanoma is the UK’s most rapidly increasing type of cancer, and yet 86% of cases are preventable.

Join us for our new podcast series, Living with Melanoma, produced by ITN Business in partnership with Melanoma Focus, a UK charity that provides guidelines and resources for patients, carers, and medical professionals.

​In the episodes, hosts Imogen Cheese and Yam Sumbwanyambe, are joined by melanoma patients who share their personal experiences of receiving a melanoma diagnosis, as well as medical professionals.

Episode One: Living with & Life After

Guests:

  • Michelle Richardson: Living with Melanoma
  • Willie Munro: Living with Melanoma
  • Jackie Hodgetts: Nurse Consultant, Head of Melanoma Focus Helpline Service, and Trustee of Melanoma Focus

Discussion Highlights:

  • Impacts on Patients and Families:
  • The challenges and emotional toll of a melanoma diagnosis extend beyond the patient, affecting the entire family.
  • Importance of understanding and addressing these wide-ranging impacts.

Episode Two: Skin Tone

Guests:

  • Carole: Living with Melanoma
  • Professor Catherine Harwood: Consultant Dermatologist
  • Doctor Suchitra Chinthapalli: Consultant Dermatologist

Discussion Highlights:

  • How Skin Tone can impact disease presentation and diagnosis
  • Carole’s experience of Acral Lentiginous Melanoma
  • UV protection for various skin tones

Episode Three: Myth Busting & Prevention

Guests:

  • Leah Roach: living with melanoma
  • Jaime Nobbs: Skin Cancer Nurse Specialist
  • Susanna Daniels: Melanoma Focus CEO

Discussion Highlights:

  • Melanoma is highly preventable; Wear a broad-spectrum high-factor sunscreen and reapply regularly; shade/clothing
  • Melanoma can affect all ages and is fairly common in younger people. It is the second and third most common cancer in males and females respectively, between 15-44 years of age in England (ONS)
  • Know your skin and contact your GP if you notice any changes in existing moles/lesions or a new mole/lesion

This podcast series has been sponsored by funding from MSD. The podcast episodes have been reviewed by MSD for factual accuracy only. MSD has had no input on content and ITN has retained full editorial control.